Psychedelics Investing

Compass Pathways to announce fourth quarter and year-end financial results on February 27th, 2025

Life Science Investing News

Compass Pathways to announce fourth quarter and year-end financial results on February 27th, 2025

Life Science Investing News

Compass Pathways to announce fourth quarter and year-end financial results on February 27th, 2025

Life Science Investing News

Compass Pathways to announce fourth quarter and year-end financial results on February 27th, 2025

Life Science Investing News

Compass Pathways to announce fourth quarter and year-end financial results on February 27th, 2025

Life Science Investing News

Compass Pathways to announce fourth quarter and year-end financial results on February 27th, 2025

Life Science Investing News

Compass Pathways to announce fourth quarter and year-end financial results on February 27th, 2025

Life Science Investing News

Compass Pathways to Participate in Oppenheimer 35th Annual Healthcare Life Sciences Conference

Life Science Investing News

Compass Pathways to Participate in Oppenheimer 35th Annual Healthcare Life Sciences Conference

Life Science Investing News

Compass Pathways Appoints Steve Levine, M.D., as Chief Patient Officer

Life Science Investing News

Compass Pathways Appoints Steve Levine, M.D., as Chief Patient Officer

Life Science Investing News

Compass Pathways Announces Pricing of Underwritten Offering

Life Science Investing News

Latest psychedelics News

More psychedelics News

Outlook Reports

Resource
Tech
Life Science

Browse Companies

Resource
Tech
Life Science
MARKETS
COMMODITIES
CURRENCIES
×